Search
for
Sort by
Research 511–540 of 1000+
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Resident Memory T Cells in Autoimmune Skin Diseases
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Induced Mammary Epithelial Cell-Derived Extracellular Vesicles Promote the Repair of Skin Trauma
- Multi-omics analyses, cell experiments, and network pharmacology tools identified key proteins and candidate drugs for alopecia areata treatment
- dsRNA Released by Tissue Damage Activates TLR3 to Drive Skin Regeneration
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- An ERK-dependent molecular switch antagonizes fibrosis and promotes regeneration in spiny mice ( <i>Acomys</i> )
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Alopecia areata: medical treatments
- Biologics in the management of childhood atopic dermatitis
- Alopecia Areata: An Updated Review for 2023
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- What is behind the ‘swarm of bees’ in alopecia areata
- Effects of Natural Herbal Marker Compounds on Human Dermal Papilla Cell Growth Regulation
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report